Podcast

Pharmacy Focus Episode 31: What's New in COVID-19 Vaccine Mandates

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

In this week’s episode, we will be discussing regulation and legislation surrounding COVID-19 vaccine mandates with principal of Lanton Law Ron Lanton and pharmacist attorney Ned Milenkovich. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Related Videos
Doctor hands making a vaccination in the shoulder of patient
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Ashley Pugh, PharmD, and Lauren Angelo, PharmD, MBA
Image credit: terovesalainen - stock.adobe.com
Related Content
COVID-19 vaccine -- Image credit: Daniel Jędzura | stock.adobe.com
October 18th 2024

FDA Places Clinical Hold on Novavax COVID-19/Influenza and Standalone Influenza Vaccine Trials

Gillian McGovern, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Neurons cells concept
October 12th 2024

QSM Scans Indicate Brainstem Damage is Key to Long-Lasting Physical, Psychiatric Effects of Severe COVID-19

Luke Halpern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Antibodies work to neutralize SARS-CoV-2 by binding to the S protein and blocking entry (ACE2) into a host cells
October 9th 2024

Dual-Role SARS-CoV-2 Antibody Discovered, Both Assisting and Blocking Virus Depending on Variant

Luke Halpern, Assistant Editor
Immunization, Covid, Mental Illness | Image Credit: New Africa - stock.adobe.com
October 8th 2024

No Difference Observed for Any Mental Illness and Uptake of First COVID-19 Vaccine Dose For Patients With, Without Mental Illness

Ashley Gallagher, Associate Editor